| Metric | Q3 2025 | Q2 2025 | Q3 2024 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $1.3B | $1.3B | $1.2B | 2.9% | 6.6% |
| Op. Income | $192M | $179M | $182M | 6.8% | 5.5% |
| Gross Margin | 36.4% | 35.9% | 35.6% | 0.5pp | 0.7pp |
| Net Margin | 11.3% | 10.6% | 11.0% | 0.7pp | 0.3pp |
| EPS (Diluted) | $0.83 | $0.75 | $0.73 | 10.7% | 13.7% |
| Free Cash Flow | $292M | $153M | $210M | 91.2% | 39.1% |
| Item | Amount |
|---|---|
| REVENUE | $1.3B |
| Cost of Revenue | $822M |
| GROSS PROFIT | $470M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $262M |
| Other Expenses | $16M |
| Operating Expenses | $278M |
| Cost & Expenses | $1.1B |
| OPERATING INCOME | $192M |
| Interest Income | $5M |
| Interest Expense | $18M |
| Other Income/Expenses | -$2M |
| INCOME BEFORE TAX | $189M |
| Income Tax Expense | $44M |
| Net Income from Continuing Ops | $146M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $146M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $146M |
| D&A | $27M |
| EBIT | $202M |
| EBITDA | $229M |
| EPS | $1 |
| EPS Diluted | $1 |
| Item | Amount |
|---|---|
| REVENUE | $1.3B |
| Cost of Revenue | $822M |
| GROSS PROFIT | $470M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $262M |
| Other Expenses | $16M |
| Operating Expenses | $278M |
| Cost & Expenses | $1.1B |
| OPERATING INCOME | $192M |
| Interest Income | $5M |
| Interest Expense | $18M |
| Other Income/Expenses | -$2M |
| INCOME BEFORE TAX | $189M |
| Income Tax Expense | $44M |
| Net Income from Continuing Ops | $146M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $146M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $146M |
| D&A | $27M |
| EBIT | $202M |
| EBITDA | $229M |
| EPS | $1 |
| EPS Diluted | $1 |
| Item | Amount |
|---|---|
| Net Income | $146M |
| Depreciation & Amortization | $27M |
| Stock-Based Compensation | $0 |
| Deferred Income Tax | $0 |
| Other Non-Cash Items | $34M |
| Change in Working Capital | $102M |
| OPERATING CASH FLOW | $308M |
| Capital Expenditure | -$16M |
| Acquisitions (Net) | $237.0K |
| Purchases of Investments | $0 |
| Sales/Maturities of Investments | $0 |
| Other Investing Activities | -$3M |
| NET CASH FROM INVESTING | -$19M |
| Net Debt Issuance | -$94M |
| Common Stock Repurchased | -$90M |
| Common Dividends Paid | -$29M |
| Other Financing Activities | -$955.0K |
| NET CASH FROM FINANCING | -$209M |
| FREE CASH FLOW | $292M |
| Net Change in Cash | $78M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $741M |
| Short-Term Investments | $0 |
| Net Receivables | $1.3B |
| Inventory | $0 |
| Other Current Assets | $30M |
| TOTAL CURRENT ASSETS | $2.2B |
| PP&E (Net) | $361M |
| Goodwill | $1.8B |
| Intangible Assets | $71M |
| Long-Term Investments | $30M |
| Tax Assets | $254M |
| Other Non-Current Assets | $651M |
| TOTAL NON-CURRENT ASSETS | $3.2B |
| TOTAL ASSETS | $5.4B |
| Account Payables | $35M |
| Short-Term Debt | $376M |
| Deferred Revenue | $129M |
| Other Current Liabilities | $522M |
| TOTAL CURRENT LIABILITIES | $1.5B |
| Long-Term Debt | $827M |
| Deferred Revenue NC | $131M |
| Deferred Tax Liabilities | $16M |
| Other Non-Current Liabilities | $219M |
| TOTAL NON-CURRENT LIABILITIES | $1.4B |
| TOTAL LIABILITIES | $2.8B |
| Common Stock | $2M |
| Additional Paid-In Capital | $2.0B |
| Retained Earnings | $1.4B |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | -$822M |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $2.5B |
| Minority Interest | $0 |
| TOTAL EQUITY | $2.5B |
| TOTAL LIABILITIES & EQUITY | $5.4B |
| Total Debt | $1.4B |
| Net Debt | $688M |
